A multicentre, randomised placebo controlled, parallel group clinical trial to evaluate the anti-neoplastic effects of Taurolidine in patients undergoing curative surgery for non-metastatic colon cancer.

Trial Profile

A multicentre, randomised placebo controlled, parallel group clinical trial to evaluate the anti-neoplastic effects of Taurolidine in patients undergoing curative surgery for non-metastatic colon cancer.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Sep 2014

At a glance

  • Drugs Taurolidine (Primary)
  • Indications Colon cancer
  • Focus Biomarker; Pharmacodynamics; Therapeutic Use
  • Sponsors Geistlich
  • Most Recent Events

    • 01 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top